BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hofheinz RD, Beyer U, Al-Batran SE, Hartmann JT. Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives. Onkologie 2008;31:271-81. [PMID: 18497518 DOI: 10.1159/000122590] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 El Hosry L, Di Giorgio C, Birer C, Habib J, Tueni M, Bun SS, Herbette G, De Meo M, Ollivier E, Elias R. In vitro cytotoxic and anticlastogenic activities of saxifragifolin B and cyclamin isolated from Cyclamen persicum and Cyclamen libanoticum. Pharm Biol 2014;52:1134-40. [PMID: 24649909 DOI: 10.3109/13880209.2013.879600] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 An D, Na C, Bielawski J, Hannun YA, Kasper DL. Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine. Proc Natl Acad Sci U S A 2011;108 Suppl 1:4666-71. [PMID: 20855611 DOI: 10.1073/pnas.1001501107] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
3 Roa-Linares VC, Miranda-Brand Y, Tangarife-Castaño V, Ochoa R, García PA, Castro MÁ, Betancur-Galvis L, San Feliciano A. Anti-Herpetic, Anti-Dengue and Antineoplastic Activities of Simple and Heterocycle-Fused Derivatives of Terpenyl-1,4-Naphthoquinone and 1,4-Anthraquinone. Molecules 2019;24:E1279. [PMID: 30986933 DOI: 10.3390/molecules24071279] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Shuhendler AJ, Cheung RY, Manias J, Connor A, Rauth AM, Wu XY. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells. Breast Cancer Res Treat 2010;119:255-69. [PMID: 19221875 DOI: 10.1007/s10549-008-0271-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
5 Guainazzi A, Schärer OD. Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy. Cell Mol Life Sci 2010;67:3683-97. [PMID: 20730555 DOI: 10.1007/s00018-010-0492-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
6 Sun Y, Ge Y, Fu Y, Yan L, Cai J, Shi K, Cao X, Lu C. Mitomycin C induces fibroblasts apoptosis and reduces epidural fibrosis by regulating miR-200b and its targeting of RhoE. European Journal of Pharmacology 2015;765:198-208. [DOI: 10.1016/j.ejphar.2015.08.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
7 Krause P, Rave-Fränk M, Wolff HA, Becker H, Christiansen H, Koenig S. Liver sinusoidal endothelial and biliary cell repopulation following irradiation and partial hepatectomy. World J Gastroenterol 2010; 16(31): 3928-3935 [PMID: 20712054 DOI: 10.3748/wjg.v16.i31.3928] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kostková H, Etrych T, Říhová B, Kostka L, Starovoytová L, Kovář M, Ulbrich K. HPMA Copolymer Conjugates of DOX and Mitomycin C for Combination Therapy: Physicochemical Characterization, Cytotoxic Effects, Combination Index Analysis, and Anti-Tumor Efficacy: HPMA Copolymer Conjugates for Combination Therapy …. Macromol Biosci 2013;13:1648-60. [DOI: 10.1002/mabi.201300288] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
9 Zhang Y, Wang Q, Xu Y, Sun J, Ding Y, Wang L, Chen B, Sun K, Chen J. Mitomycin C Inhibits Esophageal Fibrosis by Regulating Cell Apoptosis and Autophagy via lncRNA-ATB and miR-200b. Front Mol Biosci 2021;8:675757. [PMID: 34079820 DOI: 10.3389/fmolb.2021.675757] [Reference Citation Analysis]
10 Song H, Chen T, Zhang B, Ma Y, Wang Z. An integrated microfluidic cell array for apoptosis and proliferation analysis induction of breast cancer cells. Biomicrofluidics 2010;4:44104. [PMID: 21042433 DOI: 10.1063/1.3497376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
11 Bueren-Calabuig JA, Negri A, Morreale A, Gago F. Rationale for the opposite stereochemistry of the major monoadducts and interstrand crosslinks formed by mitomycin C and its decarbamoylated analogue at CpG steps in DNA and the effect of cytosine modification on reactivity. Org Biomol Chem 2012;10:1543-52. [PMID: 22222915 DOI: 10.1039/c1ob06675g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tanasova M, Sturla SJ. Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents. Chem Rev 2012;112:3578-610. [PMID: 22482429 DOI: 10.1021/cr2001367] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
13 Lee PC, Kakadiya R, Su TL, Lee TC. Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells. Neoplasia 2010;12:376-87. [PMID: 20454509 DOI: 10.1593/neo.10110] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
14 Olano C, Méndez C, Salas JA. Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis. Nat Prod Rep 2009;26:628-60. [PMID: 19387499 DOI: 10.1039/b822528a] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 7.4] [Reference Citation Analysis]
15 Werner D, Atmaca A, Pauligk C, Pustowka A, Jäger E, Al-Batran SE. Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma. Cancer Med. 2013;2:325-333. [PMID: 23930209 DOI: 10.1002/cam4.77] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
16 Di Giorgio C, Boyer L, De Meo M, Laurant C, Elias R, Ollivier E. In vitro and in vivo antimutagenic effects of DIG, a herbal preparation of Berberis vulgaris, Taraxacum officinale and Arctium lappa, against mitomycin C. J Nat Med 2015;69:267-77. [DOI: 10.1007/s11418-015-0886-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
17 Sørensen O, Andersen A, Olsen H, Alexandr K, Ekstrøm PO, Giercksky KE, Flatmark K. Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study. BMC Cancer 2010;10:469. [PMID: 20809961 DOI: 10.1186/1471-2407-10-469] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
18 Cai X, Yang X, Cai J, Wu S, Chen Q. Atomic Force Microscope-Related Study Membrane-Associated Cytotoxicity in Human Pterygium Fibroblasts Induced by Mitomycin C. J Phys Chem B 2010;114:3833-9. [DOI: 10.1021/jp910682q] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]